(Q51675091)

9 April 2018

title

Glucagon control of fasting glucose in man. (English)

1 reference

9 April 2018

1 reference

8

A V Schally

1 reference

9 April 2018

G. Michael Besser

5

object named as

G M Besser

1 reference

9 April 2018

author name string

F P Alford

1

1 reference

9 April 2018

S R Bloom

2

1 reference

9 April 2018

J D Nabarro

3

1 reference

9 April 2018

R Hall

4

1 reference

9 April 2018

D H Coy

6

1 reference

9 April 2018

A J Kastin

7

1 reference

9 April 2018

language of work or name

English

0 references

publication date

1 October 1974

1 reference

9 April 2018

number of pages

4

1 reference

inferred from page(s)

published in

The Lancet

1 reference

9 April 2018

volume

2

1 reference

9 April 2018

page(s)

974-977

1 reference

9 April 2018

issue

7887

1 reference

9 April 2018

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

1 reference

7 January 2021

Glucagon levels and metabolic effects in fasting man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Effects of Starvation on Plasma Pancreatic Glucagon in Normal Man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Portal and Peripheral Vein Immunoreactive Glucagon Concentrations After Arginine or Glucose Infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Solid phase synthesis of growth hormone-release inhibiting factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Hormones of the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Effect of glucagon on glucose turnover and plasma free fatty acids in depancreatized dogs maintained on matched insulin infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Abnormal alpha cell function in diabetics response to insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

Abnormalities of glucagon metabolism in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992071-6

7 January 2021

10.1016/S0140-6736(74)92071-6

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fszbwmsh25eotjf6uhfnebu2dm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_fszbwmsh25eotjf6uhfnebu2dm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fszbwmsh25eotjf6uhfnebu2dm

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/fszbwmsh25eotjf6uhfnebu2dm

30 July 2022